HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.69
Day range
$0.68 - $0.70
Year range
$0.27 - $0.82
Market cap
748.60M USD
Avg Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 40.21M | 113.85% |
Operating expense | 5.53M | 19.86% |
Net income | -5.88M | -1,055.66% |
Net profit margin | -14.63 | -547.40% |
Earnings per share | — | — |
EBITDA | 22.09M | 415.05% |
Effective tax rate | -942.99% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.74M | 158.56% |
Total assets | 111.34M | 26.74% |
Total liabilities | 63.66M | 115.09% |
Total equity | 47.68M | — |
Shares outstanding | 1.07B | — |
Price to book | 17.18 | — |
Return on assets | 52.23% | — |
Return on capital | 91.34% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.88M | -1,055.66% |
Cash from operations | 14.78M | 369.90% |
Cash from investing | -218.20K | 86.88% |
Cash from financing | -4.13M | -2,261.66% |
Net change in cash | 10.43M | 698.22% |
Free cash flow | 7.02M | 4,080.94% |
About
Founded
1997
Headquarters
Website
Employees
68
